On April 18, LIVZON PHARMA (01513) spent 4.907 million RMB to repurchase 142,800 A-shares.
Li Zhu Pharmaceuticals (01513) announced that on April 18, 2025, it would invest 4.907 million yuan (...
LIVZON PHARMA (01513) announced that on April 18, 2025, it spent 4.907 million yuan to repurchase 142,800 A shares, at a repurchase price of 34.28-34.44 yuan per share.
Related Articles
Lingyuan Iron & Steel (600231.SH) plans to repurchase shares worth 50 million to 100 million yuan.
G.A. Holdings (08126) appoints Lin Juzheng as the chairman of the audit committee and remuneration committee.
China Construction Bank Corporation (00939): Jin Panshi resigns from the position of Chief Information Officer.
Lingyuan Iron & Steel (600231.SH) plans to repurchase shares worth 50 million to 100 million yuan.
G.A. Holdings (08126) appoints Lin Juzheng as the chairman of the audit committee and remuneration committee.
China Construction Bank Corporation (00939): Jin Panshi resigns from the position of Chief Information Officer.
RECOMMEND6
Spokesperson of the Ministry of Commerce responds to reporters' questions on the United States' use of tariff measures to pressure other countries to restrict economic and trade cooperation with China.
21/04/2025
Wall Street identifies "tariff safe haven": Asia's essential consumer stocks.
21/04/2025
Tariffs provoke dissatisfaction among American people, Trump's approval rating on economy hits a new low.
21/04/2025
